# What Are 'Ozempic Feet?' Doctors Explain Latest GLP-1 Side Effect From Weight Loss
Rapid weight loss from GLP-1 receptor agonist medications like semaglutide (Ozempic, Wegovy) can trigger a cosmetic condition doctors are calling "Ozempic feet." The condition involves loose, sagging skin on the feet and ankles that develops when people lose weight quickly without the skin tightening to match their new body size.
The phenomenon stems from basic skin physiology. When someone loses significant weight over weeks or months, their skin doesn't always contract at the same pace. This is particularly noticeable on the feet, where the skin has less elasticity and fewer supporting muscles compared to other body areas. The rapid fat loss leaves behind excess tissue that appears wrinkled, deflated, or hanging.
Dermatologists note that "Ozempic feet" isn't dangerous, but patients often find it cosmetically distressing. The condition typically develops after losing 20 or more pounds within a few months, though individual results vary based on age, genetics, and skin quality.
Several treatment options exist for those bothered by the appearance. Minimally invasive procedures like dermal fillers can restore volume under the skin. Radiofrequency treatments and laser therapy stimulate collagen production to tighten loose skin. In more severe cases, surgical skin removal may be necessary, though this leaves scars.
Prevention strategies focus on pacing weight loss. Slower weight loss allows skin time to adapt gradually. Maintaining hydration, using moisturizers, and staying active with strength training can support skin elasticity during weight loss.
Doctors emphasize that while GLP-1 medications produce remarkable weight loss results for many patients, the cosmetic effects deserve discussion during treatment planning. Those considering these medications should talk